Cellular immunotherapy for B cell cancers shows promise

Bookmark and Share
Published: 7 Dec 2019
Views: 358
Dr Bahram Valamehr - Fate Therapeutics Inc., San Diego, USA

Dr Bahram Valamehr presents data from a study looking at novel off-the-shelf CAR NK product FT596 during a press conference the ASH 2019 meeting.

The study evaluated the products engineered persistence for the treatment of B Cell malignancies.

Read more about the study here

Watch our interview with Dr Valamehr here